glp-1 agonist indications Drugs: Where We Are and Where We're Going — Summit Re GLP-1 receptor agonists and next-generation

For weight loss that may have stalled on tirzepatide, the resources about plateaus on GLP-1 therapy provide useful framing that applies regardless of which specific compound is involved

Unlike injectable obesity drugs, which are peptides designed to mimic the appetite-controlling GLP-1 hormone, orforglipron is a small molecule pill that is easier to manufacture and package, said Kenneth Custer, president of Lilly's cardiometabolic health division

Trials are in progress for other outcomes, such as breast cancer and neurocognitive disorders

It may only be available through clinical trials or approved research programmes

[1] Orforglipron is also chemically different from previous oral GLP-1s

Unlike GLP-1, GIP can promote glucagon secretion in normal and hypoglycemic states, and inhibit it in hyperglycemia, thus acting as a bifunctional hormone to maintain blood glucose homeostasis